TrialInvestigational new drugs2017

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.

Khaldoun Almhanna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.